Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Barchart Premier: The most comprehensive method for keeping track of all your investments. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Capricor Therap (CAPR)

Capricor Therap (CAPR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Capricor Therap 10865 Road to the Cure Suite 150 San Diego CA 92121 USA

www.capricor.com Employees: 160 P: 858-727-1755

Sector:

Medical

Description:

Capricor Therapeutics, Inc. is a biotechnology company. It is focused on the development of novel therapeutics to prevent and treat heart disease. The Company has two drug candidates in development: Cenderitide and CU-NP. Capricor Therapeutics, Inc., formerly known as Nile Therapeutics, Inc., is based in San Mateo, California.

Key Statistics

Overview:

Market Capitalization, $K 1,106,375
Enterprise Value, $K 1,095,085
Shares Outstanding, K 45,718
Float, K 40,918
% Float 89.50%
Short Interest, K 5,064
Short Float 11.08%
Days to Cover 4.60
Short Volume Ratio 0.61
% of Insider Shareholders 10.50%
% of Institutional Shareholders 21.68%

Financials:

Annual Sales, $ 22,270 K
Annual Net Income, $ -40,470 K
Last Quarter Sales, $ 0 K
Last Quarter Net Income, $ -24,570 K
EBIT, $ -86,680 K
EBITDA, $ -85,250 K

Growth:

1-Year Return 72.90%
3-Year Return 470.75%
5-Year Return 267.78%
5-Year Revenue Growth 2,104.95%
5-Year Earnings Growth 44.17%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.54 on 11/10/25
Next Earnings Date 03/18/26
Earnings Per Share ttm -1.80
EPS Growth vs. Prev Qtr 5.26%
EPS Growth vs. Prev Year -42.11%
Annual Dividend & Yield (Paid) 0.00 (0.00%)
Annual Dividend & Yield (Fwd) 0.00 (0.00%)
Dividend Payout Ratio 0.00%
Most Recent Split 1-10 on 06/05/19

CAPR Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward 39.18
Price/Earnings to Growth N/A
Return-on-Equity % -71.00%
Return-on-Assets % -56.13%
Profit Margin % -181.72%
Debt/Equity 0.00
Price/Sales 98.69
Price/Cash Flow N/A
Price/Book 13.27
Book Value/Share 1.83
Interest Coverage -1.72
60-Month Beta 0.22
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar